Bustoros, Mark

Publications

Sort by

Co-Author Network

selected publications

Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemia. 2023 GET IT
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. Cancer cell. 2022 Academic Article GET IT
Times cited: 4
Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance. Frontiers in oncology. 2022 Review GET IT
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes. Nature communications. 2022 Academic Article GET IT
Times cited: 6
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study. The Lancet. Haematology. 2022 Academic Article GET IT
Times cited: 12
Regular Aspirin Use and Mortality in Patients with Multiple Myeloma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2021 Academic Article GET IT
Times cited: 1
An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features. Cancers. 2021 Review GET IT
Times cited: 8
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration. Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Academic Article GET IT
Times cited: 18
Placental extracellular vesicles-associated microRNA-519c mediates endotoxin adaptation in pregnancy. American journal of obstetrics and gynecology. 2021 Academic Article GET IT
Times cited: 11
Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia. Leukemia research. 2020 Academic Article GET IT
Times cited: 12
Genome instability in multiple myeloma. Leukemia. 2020 Review GET IT
Times cited: 43
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Nature communications. 2020 Academic Article GET IT
Times cited: 68
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 81
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nature cancer. 2020 Academic Article GET IT
Times cited: 141
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Review GET IT
Times cited: 77
Reply to F.D. Leonard. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Comment GET IT
Bone marrow niche in multiple myeloma and its precursor states. HemaSphere. 2019 Academic Article GET IT
Times cited: 1
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 48
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group. American journal of hematology. 2019 Letter GET IT
Times cited: 9
Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients. Blood. 2018 Letter GET IT
Times cited: 26
Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia. PloS one. 2018 Academic Article GET IT
Times cited: 16
Advancements in Nanomedicine for Multiple Myeloma. Trends in molecular medicine. 2018 Review GET IT
Times cited: 17
Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. The Journal of clinical investigation. 2018 Academic Article GET IT
Times cited: 62
Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma. Nature communications. 2018 Academic Article GET IT
Times cited: 126
A Rare Case of Composite Dural Extranodal Marginal Zone Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Frontiers in neurology. 2018 Review GET IT
Times cited: 26
Established and Novel Prognostic Biomarkers in Multiple Myeloma. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2017 Review GET IT
Times cited: 23
Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor. Neoplasia (New York, N.Y.). 2016 Academic Article GET IT
Times cited: 29
Traumatic brain injury and subsequent glioblastoma development: Review of the literature and case reports. Surgical neurology international. 2016 Academic Article GET IT
Times cited: 26
Adult Primary Spinal Epidural Extraosseous Ewing's Sarcoma: A Case Report and Review of the Literature. Case reports in neurological medicine. 2016 Academic Article GET IT
Times cited: 3

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Characterization of the genomic and transcriptional landscape and role of tumor immune environment in multiple myeloma with extramedullary disease awarded by Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator 2022 - 2023

more ...

less ...

Background

education and training

M.B.,B.Ch., Alexandria University, Faculty of Medicine (Egypt) 2011

Contact

full name

Mark Bustoros

primary email

mab4033@med.cornell.edu

VIVO Weill Cornell Medical College

Mark Bustoros Assistant Professor of Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email